Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 5/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 4/20 | 0.32 |
| ▸ | FEN1 | P39748 | 4/20 | 0.32 |
| ▸ | ACACB | O00763 | 3/20 | 0.32 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.32 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11025636 | 0.95 | SCN9A (0.35) | FPR2SCN9AACACBL3MBTL1HCRTR2 | |
| SCHEMBL15381582 | 0.92 | SCN9A (0.38) | FPR2SCN9AALOX5APFEN1L3MBTL1 | |
| SCHEMBL19674971 | 0.92 | FPR2 (0.33) | FPR2SCN9AALOX5APFEN1ACACB | |
| SCHEMBL19199307 | 0.91 | SCN9A (0.34) | FPR2SCN9AACACBL3MBTL1HCRTR2 | |
| SCHEMBL14922577 | 0.90 | ALOX5AP (0.35) | FPR2SCN9AALOX5APFEN1L3MBTL1 | |
| SCHEMBL14922666 | 0.90 | ALOX5AP (0.35) | FPR2SCN9AALOX5APFEN1L3MBTL1 | |
| SCHEMBL15381708 | 0.90 | NAAA (0.35) | FPR2SCN9AALOX5APFEN1ACACB | |
| SCHEMBL15381634 | 0.90 | NAAA (0.35) | FPR2SCN9AALOX5APFEN1ACACB | |
| SCHEMBL15381627 | 0.90 | SCN9A (0.39) | FPR2SCN9AALOX5APFEN1CYP1A2 | |
| SCHEMBL14767033 | 0.90 | NAAA (0.36) | SCN9AHCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2484658-B1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2017-12-06 | — | — | EP | disclosed |
| EP-2484658-B1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-9109157-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition and liquid crystal display device using the same | JNC CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| US-9109157-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition and liquid crystal display device using the same | JNC CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| US-9109157-B2 | Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition and liquid crystal display device using the same | JNC CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| EP-2484658-A1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2012-08-08 | — | — | EP | disclosed |
| EP-2484658-A1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-26 | — | — | US | disclosed |
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-26 | — | — | US | disclosed |
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-26 | — | — | US | disclosed |
| WO-2011040373-A1 | LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | チッソ株式会社 (JP) | 2011-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190897-A1 | LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | H1-0, EFHD2, CCND2 | FPR2 1718/4885SCN9A 401/4885ALOX5AP 2460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.